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Abstract 
Aims  To discuss ethical issues that may arise in using WWA to monitor illicit drug use in the 
general population and in entertainment precincts, prisons, schools and work-places. 
Method  Review current applications of WWA and identify ethical and social issues that may 
be raised with current and projected future uses of this method. 
Results  Wastewater analysis (WWA) of drug residues is a promising method of monitoring 
illicit drug use that may overcome some limitations of other monitoring methods. When used 
for monitoring purposes in large populations, WWA does not raise major ethical concerns 
because individuals are not identified and the prospects of harming residents of catchment 
areas are remote. When WWA is used in smaller catchment areas (entertainment venues, 
prisons, schools or work-places) their results could, possibly, indirectly affect the occupants 
adversely. Researchers will need to take care in reporting their results to reduce media 
misreporting. Fears about possible use of WWA for mass individual surveillance by drug law 
enforcement officials are unlikely to be realized, but will need to be addressed because they 
may affect public support adversely for this type of research. 
Conclusions  Using wastewater analysis to monitor illicit drug use in large populations does 
not raise major ethical concerns, but researchers need to minimize possible adverse 
consequences in studying smaller populations, such as workers, prisoners and students. 
 
 
  
INTRODUCTION 
It is difficult to monitor population use of drugs such as the amphetamine-type stimulants, 
cannabis, cocaine and heroin, whose use is prohibited by law [1]. Lack of information on their 
use makes it challenging to evaluate the effectiveness of policies implemented to reduce the 
harm that these drugs cause [1–4]. Traditional methods of monitoring such as household 
surveys of illicit drug use in the population have major limitations. Illicit drug users are likely to 
be under-represented in such surveys; if included, they may under-report their drug use, 
especially of stigmatized drugs such as heroin; and they often do not know the composition of 
the drugs that they report using [1,5,6]. Surveys are also expensive to conduct, are rarely 
carried out more often than annually and there are substantial delays in publishing their 
results [2,7,8]. The use of most illicit drugs (except for cannabis) is reported by fewer than 5% 
of household survey respondents, so very large samples are needed to estimate trends in their 
use [3,4]. 
Indirect indicators of drug use, such as numbers of drug arrests and people seeking treatment 
for drug dependence [8], have different limitations. Police arrest data, for example, are 
affected by the allocation of law enforcement resources; health-related harms may not be 
recognized by illicit drug users, may not be treated by the health-care system, may not be 
recognized as drug-related by health professionals and may not be recorded as drug-related 
[8]. Unique indicators of harm among illicit drug users [e.g. fatal and non-fatal drug overdoses; 
treatment for withdrawal, dependence; and blood-borne virus (BBV) infections] only occur 
typically after years of illicit drug use [7,8], which makes them poor indicators of current drug 
use trends. 
Wastewater analysis (WWA) is a novel approach that promises to overcome these limitations 
by estimating levels of population illicit drug use from concentrations of excreted drug 
residues and metabolites in wastewater [9–11]. WWA promises to be more objective than 
survey data because it does not depend on self-reported drug use, it is not affected by low 
response rates [11,12] and it can potentially provide objective, continuous, near real-time 
estimates of drug use in the population [9,11]. 
The concept of WWA can provoke strong adverse reactions from civil rights advocates, who 
fear its possible misuse by law enforcement officials [13,14]. Hering [14], for example, has 
raised the spectre of the US government monitoring the illicit drug use of individual citizens via 
sensors in their wastewater pipes and toilets. Some US city governments have refused to allow 
sampling from their wastewater treatment systems for fear that the findings will affect the 
cities' reputations adversely [13,15]. These concerns and the issues underlying them need to 
be addressed if WWA is to be used routinely in monitoring illicit drug use. 
Ethical issues raised by WWA research and its potential future applications have been noted, 
but not discussed in any depth in the literature (for an exception see [10]). Analyses of ethical 
issues in epidemiology in general (e.g. [16]) and drug use epidemiology in particular (e.g. [17]), 
public health surveillance (e.g. [18,19]) and environmental health research [20] provide little 
guidance. These analyses deal with ethical issues that arise in research that collects data from 
individuals (e.g. on self-reported drug use, infectious disease serostatus and biological 
samples). These ethical issues include: the capacity of drug users to consent to study 
participation [17]; the circumstances in which de-identified data may be used without subject 
consent [18]; and ensuring the confidentiality of sensitive information about drug use which 
could seriously disadvantage individuals if disclosed to third parties [17]. None of these ethical 
concerns are relevant to WWA studies. Waste samples are collected from individuals without 
their consent, but these are collected as a composite sample which has been contributed to by 
a very large number of people, and so individuals are not identifiable. 
None the less, we think it essential to consider ethical concerns that may be raised by specific 
applications of WWA in public health and law enforcement. Before doing so we describe 
briefly the rationale of WWA and summarize the evidence on its strengths and limitations. We 
then outline our approach to ethical analysis and consider ethical issues that could potentially 
arise in using WWA in various settings. We begin by discussing the use of WWA to monitor 
patterns of illicit drug use in the general population, and then consider ethical issues that may 
arise if it is used in settings where smaller populations contribute to wastewater samples, such 
as entertainment areas, prisons, schools and work-places. We conclude with a brief discussion 
of civil rights issues raised by possible future uses of WWA by law enforcement officials. 
THE PROMISE OF WASTEWATER ANALYSES IN ESTIMATING ILLICIT DRUG USE 
Illicit drugs and their metabolites are excreted in faeces and urine at levels (nanograms per 
litre) that can be measured in the influent to wastewater plants using chromatography and 
mass spectrometry [9,12]. Daughton [9] first suggested that methods used to measure 
pharmaceutical drugs in waterways could be used to measure illicit drug use in the population. 
Zuccato and colleagues published the first such study of cocaine in wastewater in Milan [21]. 
Since then, studies have been conducted of drug residues and metabolites of amphetamine-
type stimulants, cannabis, cocaine and heroin and other opioids [21–23] in Australia [24,25], 
Belgium [26], Canada [27], Croatia [28], France [29], Norway [30], Spain [31] and the United 
States [32] (see recent reviews [11,12]). 
WWA is a new and developing technology, so there are methodological differences between 
studies that make it difficult to compare directly findings by different investigators [12]. These 
include variations: in wastewater sampling methods (e.g. timing, frequency and duration of 
sampling) [33]; in the metabolites and drug residues tested for and the analytical methods 
used to quantify these substances [11,12]); and in how population drug consumption is back-
calculated from drug residues [11]. 
None the less, the published studies provide promising qualitative support for the validity of 
WWA in monitoring trends in illicit drug use in the population. First, the rank order in which 
traces of illicit drugs have been detected in WWA corresponds broadly to the rank ordering of 
their self-reported use in population surveys [11,12,22]. Secondly, temporal variations in 
detection of drug traces correspond to variations in self-reported patterns of use. Levels of 
cocaine use, for example, are higher at weekends than on weekdays, whereas estimated levels 
of heroin use are more consistent throughout the week. Zuccato et al. [34] reported declines 
in rates of cocaine and heroin use and increases in rates of cannabis and amphetamines that 
paralleled changes in the reported use of these drugs in epidemiological surveys in Europe 
between 2007 and 2009 [34]. Thirdly, WWA studies also report geographic variations in levels 
of illicit drug use that correspond broadly with those in epidemiological surveys; within 
countries, higher levels of illicit drug use are estimated in larger than smaller cities and rural 
areas [22]; and higher rates were estimated in London than in Milan and Lugano [22]. 
We predict that WWA will not be used as a stand-alone method of monitoring illicit drug use, 
because epidemiological studies of drug use in wastewater catchment areas will be needed to 
understand WWA findings and vice versa [2,10,35]. WWA can, none the less, provide a useful 
additional indicator of illicit drug use in the population [2,10], with the very substantial 
advantages of providing cheaper, objective near real-time data on drug use in whole 
populations. 
Our approach to ethical analysis 
We consider uses of WWA by using a set of influential ethical principles that have often been 
used in assessing the ethics of biomedical and epidemiological research; namely, the principles 
of respect for autonomy, non-maleficence, beneficence and distributive justice [17,36,37]. 
Respect for autonomy 
Respect for autonomy is usually taken to mean that we should respect and not interfere with 
the actions of rational persons (who in most cultures are usually taken to be adults). In 
biomedical and epidemiological research, the principle of respect for autonomy is generally 
taken to require: that research participants give informed and voluntary consent to participate 
in research; that the confidentiality and privacy of personal information will be respected; and 
that researchers will be truthful about any risks that may arise from study participation 
[17,36]. 
Non-maleficence 
The principle of non-maleficence requires researchers to avoid causing harm, or placing 
participants at risk of harm. In biomedical research, the principle requires researchers to 
minimize the risks of direct harm to research participation [37]. 
Beneficence 
The principle of beneficence requires that research studies have a reasonable chance of 
producing benefits, and that the benefits of research outweigh any burdens or risks of 
participation [36]. 
Distributive justice 
The principle of distributive justice requires a fair and equitable distribution of the burdens 
and the benefits of research participation [37]. A fair and just research policy would aim to 
ensure: that the risks of research participation were not unfairly distributed (e.g. confined to 
the poor and indigent); and that any benefits of research participation (e.g. access to 
promising new treatments) were shared fairly by all who may potentially benefit [36]. 
The assessment of whether a research proposal satisfies these requirements is usually 
undertaken by an independent ethics review body or Institutional Review Board [37,38]. 
ETHICAL ISSUES IN WWA IN THE GENERAL POPULATION 
The use of WWA to study trends in illicit drug use in large catchment areas does not raise any 
major ethical issues when evaluated using the principles of respect for autonomy (consent and 
confidentiality) and non-maleficence (direct harm to participants). It is impossible to identify 
any individual because wastewater samples come from an environmental source, so 
confidential information is protected. Because individuals cannot be identified they cannot be 
harmed directly by such studies. There is a possibility of indirect harm—such as stigmatization 
of residents in a wastewater catchment area—but this is remote because the catchment areas 
used for population monitoring purposes typically include 10 000 or more people (often 
several hundred thousand), and the estimated rates of illicit drug use in these catchment areas 
are likely to be much lower than 10%. Given the negligible risk of harm, consent is not 
required. It would, in any event, not be possible to seek informed consent of all individuals—
residents and visitors—who contributed to a wastewater sample. 
WWA satisfies the principle of beneficence because it potentially provides non-intrusive 
monitoring of temporal trends in illicit drugs use within the population of a large catchment 
area. It can also identify new illicit drugs that may be used and it can be used to evaluate the 
effectiveness of policies that aim to reduce the supply of or demand for drugs. Its findings can 
also potentially be used to inform drug users of the identity of the substances that they may, 
perhaps unknowingly, be using [39]. The results of WWA studies can therefore potentially 
improve public health, the health of illicit drug users and the evaluation of law enforcement 
efforts to reduce illicit drug supply. 
Distributive justice is also well served by WWA studies. No social groups are singled out or 
even potentially identifiable in such studies, because the whole population of the catchment 
area contributes to its findings and drug users may benefit from such studies. 
For all these reasons, we argue that WWA studies of large populations do not raise major 
ethical issues. This was also the conclusion of an Australian research ethics committee that 
ruled that ethical approval was not required for wastewater studies undertaken by the 
authors. 
ETHICAL ISSUES IN WWA STUDIES IN SPECIAL VENUES 
Entertainment venues 
WWA methods could potentially be used to monitor illicit drug use in entertainment venues, 
rock concerts or festivals, dance parties or pubs and nightclubs. There may be legal obstacles 
in obtaining such wastewater samples if venue operators refuse to allow their collection. 
However, it is unlikely that operators could prevent sampling from wastewater that came from 
multiple premises, and did not occur at an outlet on their property. Issues of consent and 
privacy also do not arise if the catchment area is an entertainment precinct because 
individuals cannot be identified. 
WWA studies could possibly have negative effects such as economic losses for businesses (e.g. 
pubs, clubs and hotels) within the catchment area, but this seems unlikely. The patrons of 
entertainment precincts in large cities are well known to have higher rates of illicit drug use 
than the general population. It is also unlikely that WWA studies will produce more economic 
harm to such operators than media reports of arrests or epidemiological studies of drug use or 
drug-related harms (e.g. overdoses attended by ambulances) within these areas. Any such 
hypothetical adverse social effects are likely to be outweighed by the potential public health 
benefits of improved knowledge about levels of illicit drug use in the community. Patrons of 
these precincts could also benefit from such studies if warnings were issued about the risks of 
using the illicit drugs identified in wastewater samples. Researchers should, none the less, take 
care in reporting the results of such studies to avoid causing unintended harm to residents of 
catchment areas. 
WWA studies in prisons 
There is a good case for conducting WWA studies in prisons. High proportions of prisoners are 
drug offenders and drug use occurs in prisons, albeit at a lower level than in the general 
population [40–42]. Drug use in prisons endangers the health and safety of prisoners and 
prison staff [40,42]. Drug smuggling in prisons can lead to violence and drug use may cause 
fatal overdoses and BBV infections in prisoners [42]. For these reasons, prisons make 
considerable efforts to detect drug use by prisoners, e.g. by conducting urinalyses and cell 
searches and searching prison visitors. One prison WWA study has been conducted; 
Postigo et al. [43] measured illicit drug traces in wastewater from one prison in 2009. They 
found that cannabis and cocaine were used more consistently over time than heroin and 
amphetamines, and that levels of illicit drug use in the prison were much lower than those in a 
nearby city. 
Prison WWA studies measure drug use in ways that do not identify individuals using methods 
that are much less intrusive than urinalysis and cell searches. The major ethical concerns about 
prison WWA studies arise from possible policy responses to their findings that could affect all 
inmates adversely, including those who do not use illicit drugs. Prison authorities could, for 
example, respond to WWA indications of illicit drug use by eliminating contact visits with 
families to reduce drug smuggling. This would, arguably, be a form of collective punishment. 
Such punitive responses are NOT unique to WWA studies; they could also be triggered by 
seizures of drugs, overdose deaths or positive results from urinalyses of individual prisoners. 
Researchers will, none the less, need to discuss carefully possible policy responses to their 
findings with prison officials before conducting these studies. They may want to reconsider 
their involvement if punitive sanctions are likely; and they should think carefully about the way 
in which the results of these studies are reported in the media. We recommend that 
researchers avoid identifying particular prisons to reduce the risk that the media will 
stigmatize an entire inmate population, prompting punitive policy responses. 
WWA research in schools and work-places 
WWA studies in high schools are likely to raise similar ethical objections on the part of 
teachers and schools, and parents of students to individual drug testing in this setting [44]; 
namely, that publication of research findings could stigmatize all children and young people at 
schools where WWA was performed. This would be a reasonable concern if particular schools 
were singled out for testing and named when WWA findings were made public. These 
concerns would be reduced if WWA sampling was performed in a similar manner to school 
surveys of drug use, e.g. if schools were selected randomly for sampling, if aggregate-only 
results of WWA studies in schools were reported, and if none of the participating schools were 
identified publicly. 
We doubt that WWA research in the school setting should be a high priority, because studies 
in schools may be less useful than in other settings. The only published study to date, for 
example, found much lower levels of illicit drug use in the school than in the general 
population [45]. It may also not be clear if all residues are from illicit drugs, because school 
children may be prescribed stimulant medication for attention deficit hyperactive disorder 
(ADHD), such as Dexedrine, which cannot be distinguished easily from the use of illicit 
amphetamine in WWA studies. Low levels of most illicit drug residues (apart possibly from 
cannabis) would also be expected in school wastewater because most illicit drug use in 
secondary school populations would be infrequent; regular illicit drug use is more likley to 
occur among early school leavers and in early adulthood, after students have left school [46]. 
Similar concerns are likely to be raised by WWA studies in work-places. There is considerable 
controversy about the value and acceptability of work-place illicit drug testing [47]. This 
controversy may also affect WWA studies, even though they could potentially reduce the need 
for individual drug testing, thereby affording greater privacy to workers. Moreover, it is not 
easy to conduct WWA studies in individual schools or work-places. The equipment for WWA 
studies is often in place in wastewater treatment plants, but this is not true of the effluent 
from individual buildings. Additionally, limited physical access to sewers on a premise, 
intermittent flows and highly fluctuating concentrations complicate the collection of 
representative samples. This challenges the reliable quantification of illicit drug loads and it 
may be more difficult to do so unobtrusively without stigmatizing individual work-places or 
schools. 
For these reasons, there needs to be more debate about the ethical and social justification for 
conducting WWA studies in schools and work-places. We argue that WWA studies in these 
settings should be given low priority until WWA methods have been used extensively, and 
discussed publicly, in less contentious settings such as sampling from catchment areas with 
much larger populations or that include entertainment precincts. 
POSSIBLE USES OF WWA IN DRUG LAW ENFORCEMENT 
Civil libertarians' concerns about law enforcement officials using WWA for mass surveillance of 
individual citizens via sensors in wastewater pipes and toilets (e.g. [14]) are unlikely to be 
realized, for the following reasons. First, it may not be feasible to access a pipe leading from a 
residence (e.g. from a bungalow or apartment) before it mixes with sewage from other 
residences. Secondly, the usefulness of WWA in tracking individuals will depend upon how 
many people live at or visit a residence. Thirdly, sensors that could carry out this task are not 
available, and in order to install such hypothetical devices law enforcement agencies would 
probably require a warrant. Finally, WWA would be a very expensive way for law enforcement 
officials to prove a charge of drug use, an offence that usually carries a minimal penalty. Given 
the specialist expertise required to use WWA, we think that law enforcement officials are most 
likely to be interested in using population levels of illicit drug use to assess the effectiveness of 
supply control efforts and identify new drugs in the illicit market. 
In serious criminal investigations law enforcement agencies might consider using WWA to: 
detect clandestine drug laboratories; and perhaps to support an application for a search 
warrant [48]. Many aspects of different countries' laws governing evidence and criminal 
procedure await research [48] because the legal status of wastewater is unclear, including who 
owns it [49]. These issues will require future ethical and legal scrutiny once effective methods 
have been developed and implemented for routine use. We do not think that these concerns 
about possible future uses of WWA by law enforcement officials are serious enough to prevent 
the development of WWA for population monitoring of illicit drug use. 
CONCLUSIONS 
Chemical analysis of illicit drug residues and metabolites in wastewater is a promising method 
of monitoring drug use trends in the population. It is most likely to be used in conjunction with 
population surveys, testing the purity of drug seizures and social surveys of regular drug users. 
However, it has considerable potential to serve the public good, and there is a strong prima 
facie case for developing these methods for routine use. 
WWA does not raise major ethical concerns when used for public health purposes to monitor 
illicit drug use in large populations, because individuals are not identifiable. WWA will provide 
useful information on aggregate trends in illicit drug use in the wastewater catchment area 
that can be used to evaluate the effectiveness of drug policies. 
Ethical issues may arise from concerns about possible indirect harms from using WWA in a 
prison or an entertainment venue, because the results of such studies may produce policy 
responses that could affect all occupants of these premises adversely, regardless of their drug 
use. Researchers could mitigate these risks by not identifying the location of study sites when 
publishing results. They should also consider the potential policy responses to their findings 
before conducting studies. Significant social concerns may make it difficult to conduct WWA 
studies in schools and work-place settings, and it may be advisable to give studies in these 
settings a lower priority until these methods are ready for routine use. 
Fears about possible mass use of WWA for individual surveillance by drug law enforcement 
officials are unlikely to be realized. It is none the less important for researchers to address 
these concerns because they may reduce public support for this type of monitoring. 
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